2020 European Society for Medical Oncology Congress Coverage

Save as Favorite

Sign in to receive recommendations (Learn more)

Every year, the European Society for Medical Oncology Congress brings together clinicians, researchers, and advocates to discuss the latest cancer study results. We’re proud to present our coverage below.

Research News

Adding Tecentriq to Chemotherapy Before Surgery for Early-Stage Triple-Negative Breast Cancer Improves pCR Rates

Trodelvy Improves Outcomes for Previously Treated Metastatic Triple-Negative Breast Cancer

Piqray Improves Overall Survival for Advanced-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer With PIK3CA Mutation

Adding Verzenio to Hormonal Therapy After Surgery for Early-Stage Breast Cancer With High Risk of Recurrence Reduces That Recurrence Risk

Podcast Episodes

Breast Cancer Research at ESMO 2020
Michael Method, M.D.

Verzenio Reduces Recurrence Risk for Certain Early-Stage Breast Cancers
Stephen Johnston, M.D., Ph.D.

---

Can we help guide you?

Create a profile for better recommendations

---

• Breast Self-Exam

  Breast self-exam, or regularly examining your breasts on your own, can be an important way to...

• Taking Certain Supplements Before and During Chemotherapy for Breast Cancer May Be Risky

  A small study suggests that people who took antioxidant supplements before and during...

• Tamoxifen (Brand Names: Nolvadex, Soltamox)

  Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....

---

Beta How does this work? Learn more

Are these recommendations helpful? Take a quick survey